These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2676629)

  • 1. [Screening and studies of the specificity of antinuclear antibodies in lupus erythematosus and scleroderma sera in the tumor cell monolayer substrate].
    Lüthke K; Conrad K; Frank KH
    Dermatol Monatsschr; 1989; 175(8):484-91. PubMed ID: 2676629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing HEp-2 cell line with rat liver in routine screening test for antinuclear and antinucleolar autoantibodies in autoimmune diseases.
    Prost AC; Abuaf N; Rouquette-Gally AM; Homberg JC; Combrisson A
    Ann Biol Clin (Paris); 1987; 45(6):610-7. PubMed ID: 3326434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
    Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
    Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Crithidia luciliae and Farr assays for the detection of systemic lupus erythematosus.
    Burdash NM; Teti G; Papadopoulos V
    Ann Clin Lab Sci; 1983; 13(1):49-54. PubMed ID: 6340594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of antinuclear antibody detection by indirect immunofluorescence and enzyme immunoassay in lupus patients.
    El-Chennawi FA; Mosaad YM; Habib HM; El-Degheidi T
    Immunol Invest; 2009; 38(8):839-50. PubMed ID: 19860592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinuclear antibodies in localized scleroderma.
    Takehara K; Moroi Y; Nakabayashi Y; Ishibashi Y
    Arthritis Rheum; 1983 May; 26(5):612-6. PubMed ID: 6405756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic approaches in systemic lupus erythematosus (author's transl)].
    Häcki MA; Grob PJ
    Dtsch Med Wochenschr; 1976 Jan; 101(1):13-6. PubMed ID: 1106979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect immunofluorescent assay for antinuclear antibodies on McCoy-Plovdiv serum-free cell line substrate.
    Zagorov MY; Draganov MM; Alimanska SA; Staykova ND; Stefanov RS; Trayancheva M; Kuzmanova SI; Murdjeva MA
    Comp Immunol Microbiol Infect Dis; 2007 May; 30(3):153-62. PubMed ID: 17241662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The antinuclear antibody spectrum in circumscribed forms of scleroderma].
    do Vale E; Gerstmeier H; Meurer M; Krieg T; Braun-Falco O
    Dtsch Med Wochenschr; 1986 Dec; 111(50):1922-7. PubMed ID: 3536401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and characteristics of anti-single-stranded DNA antibodies in localized scleroderma. Comparison with systemic lupus erythematosus.
    Ruffatti A; Peserico A; Rondinone R; Calligaro A; Del Ross T; Ghirardello A; Germino M; Todesco S
    Arch Dermatol; 1991 Aug; 127(8):1180-3. PubMed ID: 1863075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue specificity of antinuclear antibodies in scleroderma.
    Błaszczyk M; Beutner EH; Rogoziński T; Rzesa G; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski TP
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):761-4. PubMed ID: 107922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Crithidia luciliae kinetoplast immunofluorescence test in systemic lupus erythematosus.
    Slater NG; Cameron JS; Lessof MH
    Clin Exp Immunol; 1976 Sep; 25(3):480-6. PubMed ID: 786521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect immunofluorescence (IFA) on kinetoplasts of Trypanosoma theileri for serological diagnosis of systemic lupus erythematosus (LES) in the dog.
    Moretti A; Piergili Fioretti D
    Parassitologia; 1989; 31(2-3):183-7. PubMed ID: 2486998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of antinuclear antibodies.
    Meryhew NL; Messner RP; Tan EM
    J Rheumatol; 1983 Dec; 10(6):913-9. PubMed ID: 6363697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of substrates for the detection of antinuclear antibodies in normals and in patients with connective tissue and other diseases.
    Lipscomb MF; Cope LD; Stephens GL; Deng JS; Gilliam JN
    Diagn Immunol; 1984; 2(3):181-7. PubMed ID: 6388982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crithidia luciliae assay for antibodies to native DNA in procainamide-induced lupus erythematosus.
    Dixon JA; Mulhern LM; Whiteside TL; Luksick J
    J Rheumatol; 1980; 7(4):544-6. PubMed ID: 6999152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-NuMA antibodies: an uncommon specificity in scleroderma sera.
    Herrera-Esparza R; Avalos-Diaz E; Barbosa-Cisneros O
    Rev Rhum Engl Ed; 1999 Jun; 66(6):315-8. PubMed ID: 10418059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.